During the past decade, Lakeland Hospitals at St. Joseph conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Lakeland Hospitals at St. Joseph" are "Coronary Artery Disease" (2 trials) and "Atherosclerosis" (1 trials). Many other conditions were trialed in "Lakeland Hospitals at St. Joseph" in a lesser frequency.

Most popular intervention types in "Lakeland Hospitals at St. Joseph" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "ION™ Coronary Stent System" (1 trials), "Percutaneous coronary intervention (PCI) with paclitaxel-eluting stent (TAXUS Element) implantation" (1 trials) and "Percutaneous coronary intervention (PCI) with paclitaxel-eluting stent (TAXUS Express) placement" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lakeland Hospitals at St. Joseph" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Lakeland Hospitals at St. Joseph". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Lakeland Hospitals at St. Joseph, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lakeland Hospitals at St. Joseph, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".